The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
A Tight Junction-Associated Merlin-Angiomotin Complex Mediates Merlin's Regulation of Mitogenic Signaling and Tumor Suppressive Functions
Open accessAbstract
Summary The Merlin/NF2 tumor suppressor restrains cell growth and tumorigenesis by controlling contact-dependent inhibition of proliferation. We have identified a tight-junction-associated protein complex comprising Merlin, Angiomotin, Patj, and Pals1. We demonstrate that Angiomotin functions downstream of Merlin and upstream of Rich1, a small GTPase Activating Protein, as a positive regulator of Rac1. Merlin, through competitive binding to Angiomotin, releases Rich1 from the Angiomotin-inhibitory complex, allowing Rich1 to inactivate Rac1, ultimately leading to attenuation of Rac1 and Ras-MAPK pathways. Patient-derived Merlin mutants show diminished binding capacities to Angiomotin and are unable to dissociate Rich1 from Angiomotin or inhibit MAPK signaling. Depletion of Angiomotin in Nf2−/− Schwann cells attenuates the Ras-MAPK signaling pathway, impedes cellular proliferation in vitro and tumorigenesis in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Dalgliesh, G. L., Furge, K., Greenman, C., Chen, L., Bignell, G., Butler, A., Davies, H., Edkins, S., Hardy, C., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08672 · Cited by 1,173 · cited 2×
“In particular, a recent systematic analysis has indicated thatNF2 mutations define a subtype of non-VHL mutated clear cell renal carcinomas (ccRCCs) and targeted deletion of Nf2 in mouse renal epithelia leads to invasive carcinoma by 6–10 months of age (Dalgliesh et al., 2010; Morris and McClatchey, 2009).”
Zhang, N., Bai, H., David, K. K., Dong, J., Zheng, Y., Cai, J., Giovannini, M., Liu, P., Anders, R. A., & Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.06.015 · Cited by 804
Tight junctions and the modulation of barrier function in disease
Förster, C. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0424-9 · Cited by 613
Crosstalk between small GTPases and polarity proteins in cell polarization
Iden, S., & Collard, J. G. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2521 · Cited by 451
A Rich1/Amot Complex Regulates the Cdc42 GTPase and Apical-Polarity Proteins in Epithelial Cells
Wells, C. D., Fawcett, J. P., Traweger, A., Yamanaka, Y., Goudreault, M., Elder, K., Kulkarni, S., Gish, G., Virag, C., Lim, C., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.045 · Cited by 372
Giovannini, M., Robanus-Maandag, E., van der Valk, M., Niwa-Kawakita, M., Abramowski, V., Goutebroze, L., Woodruff, J. M., Berns, A., & Thomas, G. (2000) · Genes & Development · doi:10.1101/gad.14.13.1617 · Cited by 369
Contact-dependent inhibition of EGFR signaling by Nf2/Merlin
Curto, M., Cole, B. K., Lallemand, D., Liu, C.-H., & McClatchey, A. I. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703010 · Cited by 363
The Nf2 Tumor Suppressor, Merlin, Functions in Rac-Dependent Signaling
Shaw, R. J., Paez, J. G., Curto, M., Yaktine, A., Pruitt, W. M., Saotome, I., O'Bryan, J. P., Gupta, V., Ratner, N., Der, C. J., et al. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00009-0 · Cited by 343
NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions
Lallemand, D., Curto, M., Saotome, I., Giovannini, M., & McClatchey, A. I. (2003) · Genes & Development · doi:10.1101/gad.1054603 · Cited by 324
Merlin/NF2 Suppresses Tumorigenesis by Inhibiting the E3 Ubiquitin Ligase CRL4DCAF1 in the Nucleus
Li, W., You, L., Cooper, J., Schiavon, G., Pepe-Caprio, A., Zhou, L., Ishii, R., Giovannini, M., Hanemann, C. O., Long, S. B., et al. (2010) · Cell · doi:10.1016/j.cell.2010.01.029 · Cited by 321
p21-activated Kinase Links Rac/Cdc42 Signaling to Merlin
Xiao, G.-H., Beeser, A., Chernoff, J., & Testa, J. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100553200 · Cited by 272
Nf2 /Merlin controls progenitor homeostasis and tumorigenesis in the liver
Benhamouche, S., Curto, M., Saotome, I., Gladden, A. B., Liu, C.-H., Giovannini, M., & McClatchey, A. I. (2010) · Genes & Development · doi:10.1101/gad.1938710 · Cited by 269
Kissil, J. L., Wilker, E. W., Johnson, K. C., Eckman, M. S., Yaffe, M. B., & Jacks, T. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00382-4 · Cited by 257
Self-citationKissil, J. L., Johnson, K. C., Eckman, M. S., & Jacks, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200083200 · Cited by 254
Self-citationMolecular perspective on tight-junction assembly and epithelial polarity
MIYOSHI, J., & TAKAI, Y. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.01.008 · Cited by 230
Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse
Kalamarides, M., Niwa-Kawakita, M., Leblois, H., Abramowski, V., Perricaudet, M., Janin, A., Thomas, G., Gutmann, D. H., & Giovannini, M. (2002) · Genes & Development · doi:10.1101/gad.226302 · Cited by 224
Merlin/Neurofibromatosis Type 2 Suppresses Growth by Inhibiting the Activation of Ras and Rac
Morrison, H., Sperka, T., Manent, J., Giovannini, M., Ponta, H., & Herrlich, P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1608 · Cited by 223
Maitra, S., Kulikauskas, R. M., Gavilan, H., & Fehon, R. G. (2006) · Current Biology · doi:10.1016/j.cub.2006.02.063 · Cited by 202
Melbye, M., Cook, P., Hjalgrim, H., Begtrup, K., Simpson, G. R., Biggar, R. J., Ebbesen, P., & Schulz, T. F. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980812)77:4<554::aid-ijc14>3.0.co;2-6 · Cited by 201
Okada, T., Lopez-Lago, M., & Giancotti, F. G. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200503165 · Cited by 195
Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase
Jin, H., Sperka, T., Herrlich, P., & Morrison, H. (2006) · Nature · doi:10.1038/nature04856 · Cited by 193
Ernkvist, M., Persson, N. L., Audebert, S., Lécine, P., Sinha, I., Liu, M., Schlueter, M., Horowitz, A., Aase, K., Weide, T., et al. (2008) · Blood · doi:10.1182/blood-2008-04-153874 · Cited by 148
Self-citationLallemand, D., Manent, J., Couvelard, A., Watilliaux, A., Siena, M., Chareyre, F., Lampin-Saint-Amaux, A., Niwa‐Kawakita, M., Kalamarides, M., & Giovannini, M. (2008) · Oncogene · doi:10.1038/onc.2008.427 · Cited by 148
Alfthan, K., Heiska, L., Grönholm, M., Renkema, G. H., & Carpén, O. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313916200 · Cited by 142
Beeser, A. E., Jaffer, Z. M., Hofmann, C., & Chernoff, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502306200 · Cited by 137
Rong, R., Surace, E. I., Haipek, C. A., Gutmann, D. H., & Ye, K. (2004) · Oncogene · doi:10.1038/sj.onc.1207794 · Cited by 134
Wong, H. K., Lahdenranta, J., Kamoun, W. S., Chan, A. W., McClatchey, A. I., Plotkin, S. R., Jain, R. K., & di Tomaso, E. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3107 · Cited by 129
Ammoun, S., Flaiz, C., Ristic, N., Schuldt, J., & Hanemann, C. O. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5849 · Cited by 128
Richnau, N., & Aspenström, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103540200 · Cited by 126
Upregulation of the Rac1/JNK signaling pathway in primary human schwannoma cells
Kaempchen, K., Mielke, K., Utermark, T., Langmesser, S., & Hanemann, C. O. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg146 · Cited by 120
A Clue to the Therapy of Neurofibromatosis Type 2: NF2/Merlin Is a PAK1 Inhibitor
Hirokawa, Y., Tikoo, A., Huynh, J., Utermark, T., Hanemann, C. O., Giovannini, M., Xiao, G., Testa, J. R., Wood, J. L., & Maruta, H. (2004) · The Cancer Journal · doi:10.1097/00130404-200401000-00006 · Cited by 109
杉原, 祐., Adachi, M., Kobayashi, Y., Hamazaki, Y., Nishimura, M., Imai, T., Furuse, M., & Tsukita, S. (2007) · Genes to Cells · doi:10.1111/j.1365-2443.2007.01066.x · Cited by 101
Magic but treatable? Tumours due to loss of Merlin
Hanemann, C. O. (2007) · Brain · doi:10.1093/brain/awm249 · Cited by 91
Ernkvist, M., Birot, O., Sinha, I., Veitonmäki, N., Nyström, S., Aase, K., & Holmgren, L. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.11.018 · Cited by 89
Self-citationMerlin and the ERM proteins in Schwann cells, neurons and growth cones
Ramesh, V. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1407 · Cited by 81
Nadrin, a Novel Neuron-specific GTPase-activating Protein Involved in Regulated Exocytosis
Harada, A., Furuta, B., Takeuchi, K.-I., Itakura, M., Takahashi, M., & Umeda, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004069200 · Cited by 74
Validation of the p21-Activated Kinases as Targets for Inhibition in Neurofibromatosis Type 2
Yi, C., Wilker, E., Yaffe, M. B., Stemmer-Rachamimov, A. O., & Kissil, J. L. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0866 · Cited by 72
Self-citationMorris, Z. S., & McClatchey, A. I. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902031106 · Cited by 66
Stokowski, R. P., & Cox, D. (2000) · The American Journal of Human Genetics · doi:10.1086/302812 · Cited by 65
Fluorescence Resonance Energy Transfer Analysis of Merlin Conformational Changes
Hennigan, R. F., Foster, L. A., Fedor‐Chaiken, M., Mani, T., Gomes, M. M., Herr, A. B., & Ip, W. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00248-09 · Cited by 41
Merlin in organ size control and tumorigenesis: Hippo versus EGFR?Preprint
Yi, C., & Kissil, J. L. (2010) · Genes & Development · doi:10.1101/gad.1964810 · Cited by 37
Self-citationMerlin Inhibits Neurite Outgrowth in the CNS
Schulz, A., Geißler, K. J., Kumar, S., Leichsenring, G., Morrison, H., & Baader, S. L. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0840-10.2010 · Cited by 34
Furuta, B., Harada, A., Kobayashi, Y., Takeuchi, K., Kobayashi, T., & Umeda, M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01021.x · Cited by 25
Cited by
The Biology of YAP/TAZ: Hippo Signaling and Beyond
Piccolo, S., Dupont, S., & Cordenonsi, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00005.2014 · Cited by 1,802
Tight junctions: from simple barriers to multifunctional molecular gates
Zihni, C., Mills, C., Matter, K., & Balda, M. S. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.80 · Cited by 1,496
The Hippo pathway: regulators and regulations.
Yu, F.-X., & Guan, K.-L. (2013) · Genes & Development · doi:10.1101/gad.210773.112 · Cited by 1,231
The Hippo Signaling Pathway in Development and Disease
Zheng, Y., & Pan, D. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.06.003 · Cited by 867
The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
Johnson, R., & Halder, G. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4161 · Cited by 881
Metadata
- Authors
- Yi, C., Troutman, S., Fera, D., Stemmer-Rachamimov, A., Avila, J. L., Christian, N., Persson, N. L., Shimono, A., Speicher, D. W., Marmorstein, R., Holmgren, L., & Kissil, J. L.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2011-04
- Volume
- 19
- Issue
- 4
- Pages
- 527-540
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2051627999
- Cited by
- 260
- References
- 43
- FWCI
- 15.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.